Last reviewed · How we verify
NCT05288257
Mixed Method Study Protocol_Cognitive Non-technical Skills Learning Module for a Safe Laparoscopic Cholecystectomy
trial testing Learning Module in Learning Module in 217 participants. Status unknown.
31 January 2023
Quick facts
| Lead sponsor | RSUP Fatmawati |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 217 |
| Start date | 5 February 2022 |
| Primary completion | 31 January 2023 |
| Estimated completion | 31 January 2023 |
| Sites | 1 location across Indonesia |
Drugs / interventions tested
- Learning Module
Conditions studied
- Learning Module — all drugs for Learning Module →
- Cognitive Non-technical Skills — all drugs for Cognitive Non-technical Skills →
Sponsor
RSUP Fatmawati — full company profile →
Who can join
25 and older, any sex, with Learning Module or Cognitive Non-technical Skills. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
A mixed-methods sequential explanatory design study. The first quantitative phase will be an online survey to surgeons that includes questions related to their experience learning and performing laparoscopic cholecystectomy. The second qualitative phase will use depth interview to elaborate surgeon's experience regarding a safe laparoscopic cholecystectomy
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05288257
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other RSUP Fatmawati trials
Trials by the same sponsor.
- NCT06392516 — Ketoacid Analogues Intradialytic Effect on Inflammation · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05288257 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RSUP Fatmawati
- Last refreshed: 25 October 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05288257.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing